Annual Net Income
-$83.81 M
-$18.01 M-27.38%
December 31, 2022
Summary
- As of February 10, 2025, AGLE annual net profit is -$83.81 million, with the most recent change of -$18.01 million (-27.38%) on December 31, 2022.
- During the last 3 years, AGLE annual net income has fallen by -$5.56 million (-7.11%).
Performance
AGLE Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Net Income
-$40.11 M
+$176.97 M+81.52%
September 30, 2023
Summary
- As of February 10, 2025, AGLE quarterly net profit is -$40.11 million, with the most recent change of +$176.97 million (+81.52%) on September 30, 2023.
- Over the past year, AGLE quarterly net income has dropped by -$21.87 million (-119.96%).
Performance
AGLE Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Net Income
-$294.43 M
-$21.87 M-8.03%
September 30, 2023
Summary
- As of February 10, 2025, AGLE TTM net profit is -$294.43 million, with the most recent change of -$21.87 million (-8.03%) on September 30, 2023.
- Over the past year, AGLE TTM net income has dropped by -$208.99 million (-244.61%).
Performance
AGLE TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
AGLE Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.4% | -120.0% | -244.6% |
| 3 y3 years | -7.1% | -122.4% | -269.6% |
| 5 y5 years | -207.7% | -236.6% | -276.3% |
AGLE Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +27.4% | at low | +120.0% | +441.3% | +347.5% | at low |
| 5 y | 5-year | +27.4% | at low | +487.2% | +441.3% | +347.5% | at low |
| alltime | all time | +710.0% | at low | +2710.6% | +441.3% | >+9999.0% | at low |
Aeglea BioTherapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$40.11 M(-81.5%) | -$294.43 M(+8.0%) |
| Jun 2023 | - | -$217.08 M(+1078.4%) | -$272.56 M(+250.3%) |
| Mar 2023 | - | -$18.42 M(-2.1%) | -$77.80 M(-7.2%) |
| Dec 2022 | -$83.81 M(+27.4%) | -$18.82 M(+3.2%) | -$83.81 M(-1.9%) |
| Sep 2022 | - | -$18.23 M(-18.3%) | -$85.44 M(-2.4%) |
| Jun 2022 | - | -$22.32 M(-8.6%) | -$87.51 M(+21.5%) |
| Mar 2022 | - | -$24.44 M(+19.5%) | -$72.02 M(+9.4%) |
| Dec 2021 | -$65.80 M(-18.7%) | -$20.45 M(+0.7%) | -$65.80 M(-3.3%) |
| Sep 2021 | - | -$20.31 M(+197.3%) | -$68.07 M(+3.5%) |
| Jun 2021 | - | -$6.83 M(-62.5%) | -$65.80 M(-18.1%) |
| Mar 2021 | - | -$18.22 M(-19.8%) | -$80.38 M(-0.6%) |
| Dec 2020 | -$80.89 M(+3.4%) | -$22.71 M(+26.0%) | -$80.89 M(+1.5%) |
| Sep 2020 | - | -$18.03 M(-15.8%) | -$79.67 M(-4.3%) |
| Jun 2020 | - | -$21.42 M(+14.4%) | -$83.21 M(+4.3%) |
| Mar 2020 | - | -$18.73 M(-12.9%) | -$79.81 M(+2.0%) |
| Dec 2019 | -$78.25 M(+76.5%) | -$21.50 M(-0.4%) | -$78.25 M(+9.2%) |
| Sep 2019 | - | -$21.57 M(+19.7%) | -$71.66 M(+15.6%) |
| Jun 2019 | - | -$18.02 M(+5.0%) | -$62.00 M(+16.1%) |
| Mar 2019 | - | -$17.17 M(+15.2%) | -$53.40 M(+20.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$44.35 M(+62.8%) | -$14.90 M(+25.0%) | -$44.35 M(+23.4%) |
| Sep 2018 | - | -$11.92 M(+26.6%) | -$35.93 M(+12.7%) |
| Jun 2018 | - | -$9.41 M(+16.0%) | -$31.89 M(+9.6%) |
| Mar 2018 | - | -$8.12 M(+25.2%) | -$29.11 M(+6.9%) |
| Dec 2017 | -$27.24 M(+25.5%) | -$6.48 M(-17.7%) | -$27.24 M(+3.8%) |
| Sep 2017 | - | -$7.87 M(+18.7%) | -$26.24 M(+6.7%) |
| Jun 2017 | - | -$6.63 M(+6.2%) | -$24.60 M(+5.1%) |
| Mar 2017 | - | -$6.25 M(+13.9%) | -$23.40 M(+7.8%) |
| Dec 2016 | -$21.70 M(+92.1%) | -$5.48 M(-12.1%) | -$21.70 M(+7.4%) |
| Sep 2016 | - | -$6.24 M(+14.9%) | -$20.20 M(+16.3%) |
| Jun 2016 | - | -$5.43 M(+19.4%) | -$17.38 M(+29.9%) |
| Mar 2016 | - | -$4.55 M(+14.0%) | -$13.37 M(+18.4%) |
| Dec 2015 | -$11.29 M(+9.2%) | -$3.99 M(+16.8%) | -$11.29 M(+7.7%) |
| Sep 2015 | - | -$3.41 M(+139.2%) | -$10.49 M(+1.6%) |
| Jun 2015 | - | -$1.43 M(-42.2%) | -$10.33 M(-8.6%) |
| Mar 2015 | - | -$2.47 M(-22.4%) | -$11.29 M(+9.2%) |
| Dec 2014 | -$10.35 M | -$3.18 M(-2.1%) | -$10.35 M(+44.4%) |
| Sep 2014 | - | -$3.25 M(+35.6%) | -$7.17 M(+83.0%) |
| Jun 2014 | - | -$2.40 M(+57.6%) | -$3.92 M(+157.6%) |
| Mar 2014 | - | -$1.52 M | -$1.52 M |
FAQ
- What is Aeglea BioTherapeutics annual net profit?
- What is the all time high annual net income for Aeglea BioTherapeutics?
- What is Aeglea BioTherapeutics annual net income year-on-year change?
- What is Aeglea BioTherapeutics quarterly net profit?
- What is the all time high quarterly net income for Aeglea BioTherapeutics?
- What is Aeglea BioTherapeutics quarterly net income year-on-year change?
- What is Aeglea BioTherapeutics TTM net profit?
- What is the all time high TTM net income for Aeglea BioTherapeutics?
- What is Aeglea BioTherapeutics TTM net income year-on-year change?
What is Aeglea BioTherapeutics annual net profit?
The current annual net income of AGLE is -$83.81 M
What is the all time high annual net income for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high annual net profit is -$10.35 M
What is Aeglea BioTherapeutics annual net income year-on-year change?
Over the past year, AGLE annual net profit has changed by -$18.01 M (-27.38%)
What is Aeglea BioTherapeutics quarterly net profit?
The current quarterly net income of AGLE is -$40.11 M
What is the all time high quarterly net income for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high quarterly net profit is -$1.43 M
What is Aeglea BioTherapeutics quarterly net income year-on-year change?
Over the past year, AGLE quarterly net profit has changed by -$21.87 M (-119.96%)
What is Aeglea BioTherapeutics TTM net profit?
The current TTM net income of AGLE is -$294.43 M
What is the all time high TTM net income for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high TTM net profit is -$1.52 M
What is Aeglea BioTherapeutics TTM net income year-on-year change?
Over the past year, AGLE TTM net profit has changed by -$208.99 M (-244.61%)